CPRT delivered strong financial growth with revenues increasing to $4.6B and operating income to $1.7B, while expanding operations with six new facilities globally.
The company demonstrates healthy operational momentum with 13.9% net income growth and 22.2% operating cash flow improvement, suggesting strong execution and market demand. The expansion into new facilities across the U.S., U.K., and Spain indicates confident investment in future growth capacity.
CPRT shows robust financial health with current assets surging 30.2% to $5.8B and stockholders' equity growing 29.4% to $6.0B, while total assets expanded 19.7% to $10.1B. Operating cash flow increased 22.2% to $1.8B and net income grew 13.9% to $1.6B, demonstrating strong operational performance. The 32.1% decline in cash to $186.3M appears strategic given the substantial growth in productive assets and overall balance sheet expansion, suggesting reinvestment into growth initiatives rather than liquidity concerns.
Cash declined 32.1% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Current assets grew 30.2% — improving short-term liquidity or inventory/receivables build.
Equity base grew 29.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Operating cash flow grew 22.2% — strong conversion of earnings to cash, healthy business fundamentals.
Asset base grew 19.7% — expansion through organic growth, acquisitions, or capital deployment.
Net income grew 13.9% — bottom-line growth signals improving overall business health.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →